Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Open-market buys, last 90 days
$6,396,312
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-03-15 Kelley John P Chief Executive Officer Grant or award +213,420 1,379,931
2017-03-15 Kelley John P Chief Executive Officer Shares withheld for taxes −96,999 $0.68 $66K 1,282,932
2016-12-19 Jebsen Michael B CFO Returned to the company +49 $2.07 $101 68,256
2016-12-15 Jebsen Michael B Chief Financial Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2016-12-15 Kelley John P Chief Executive Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2016-11-23 PROEHL GERALD T Director Purchase +14,449 $1.76 $25K 29,882
2016-11-22 PROEHL GERALD T Director Purchase +15,433 $1.59 $25K 15,433
2016-11-21 Mitchum James P. Director Returned to the company +7,000 $1.51 $11K 26,000
2016-09-30 Jebsen Michael B CFO Returned to the company −49 $2.32 $114 68,305
2016-08-19 RALLIS CHRIS A Director Returned to the company +10,000 $2.50 $25K 14,490
2016-06-01 Jebsen Michael B CFO Returned to the company −55 $2.72 $150 68,354
2016-05-01 Jebsen Michael B CFO Grant or award +430 $2.72 $1K 68,409

Page 9 of 9 · 172 trades